Restricted accessResearch articleFirst published online 2019-9
A Narrative Review of FDA Human Factors Validation Requirement: The Needs of Key Stakeholders and Proposal of an Industry (Human Factors Service Providers) Maturity Assessment Tool
As part of a comprehensive Quality System Regulation (QSR), the human factors (HF) validation requirement by the Food and Drug Administration (FDA) is a relatively recent topic. Multiple issues and bottlenecks have emerged since the publication of the draft guidance in 2011. The scientific literature on the topic of ‘FDA HF validation requirement’ is mostly focused on HF methods to ensure success from that perspective. However, the development of across-the-board strategies that can address other critical factors is necessary. No previous scientific research has outlined and addressed the problems considering the QSR and the needs of key stakeholders. For that purpose, this effort presents a narrative review of how the HF requirement for medical devices and combination products developed, as well as the issues and the interventions that have taken place to address the bottlenecks. Some essential considerations such as notorious knowledge-based and process-based gaps are discussed. Similarly, because of the demands of a changing QSR, attention is brought to the need to align key stakeholders, namely manufacturers and HF service providers (HFSPs). Also, the development of an industry (HFSPs) maturity assessment tool and future research for that purpose are proposed.
Get full access to this article
View all access options for this article.
References
1.
AAMI. (2014). AAMI TIR50 Post-market surveillance of use error management.
BurlingtonD. B. (1996). Human factors and the FDA’s goals: Improved medical device design. Biomedical Instrumentation and Technology.
7.
BurnhillM. S. (1989). The rise and fall and rise of the IUD. The American Journal of Gynecologic Health.
8.
CafazzoJ.St-CyrO. (2012). From Discovery to Design: The Evolution of Human Factors in Healthcare. Healthcare Quarterly, 15(sp), 24–29. https://doi.org/10.12927/hcq.2012.22845
9.
CampoeK. R. (2013). Medical Device Usability Analyses: An Integrative Review. Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care, 2(1), 123–130. https://doi.org/10.1177/2327857913021024
10.
CarvajalC. L.MorenoA. M. (2017). The maturity of usability maturity models. In Communications in Computer and Information Science (Vol. 770, pp. 85–99). https://doi.org/10.1007/978-3-319-67383-7_7
11.
ChagparA.CafazzoJ. A. (2010). Human Factors Recommendations and Testing Considerations for FDA Premarket Medical Device Submissions. Biomedical Instrumentation & Technology, 44(s1), 33–39. https://doi.org/10.2345/0899-8205-44.s1.33
12.
ChanC. C.ChowK.MckayB.FungM.GhaniS.SimpsonI.BlakemoreJ. (2014). Challenges to Quality and Regulatory Requirements in the United States—Drugs, Medical Device, and Cell Therapy. In Chung ChowC.KwokC.BillM.FungM. (Eds.), Therapeutic Delivery Solutions (First Edit, pp. 3–34). John Wiley & Sons, Inc.
13.
ChanI. Z. (2017). Product Development and Human Factors Considerations - Navigating the Halls of FDA-CDER.
14.
ChanI. Z. (2018). Workshop on Product Development and Human Factors Considerations in FDA/CDER: Human Factors Program Updates. In Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. Boston, MA: HFES.
15.
Combination Products Coalition. (2014). Improving Patient Care through Better Combination Product Regulation. Washington, DC20037.
16.
Cooke-DaviesT. J.ArzymanowA. (2003). The maturity of project management in different industries: An investigation into variations between project management models. International Journal of Project Management, 21(6), 471–478. https://doi.org/10.1016/S0263-7863(02)00084-4
17.
CooperJ. B.NewbowerR. S.KitzR. J. (1984). An analysis of major errors and equipment failures in anesthesia management: Considerations for prevention and detection. Anesthesiology. https://doi.org/10.1097/00000542-198401000-00008
CrosbyP. B. (1979). Quality is free: The art of making quality certain. New York: New American Library. https://doi.org/10.2172/1025774
22.
Del GiudiceK.HaleK.JohnstonM. (2015). Development of a Scale for Quantifying a System’s Human Factors Readiness. Procedia Manufacturing, 3, 5192–5198. https://doi.org/10.1016/j.promfg.2015.07.580
FDA. (2019). Compliance Policy for Combination Product Postmarketing Safety Reporting Immediately in Effect Guidance for Industry and Food and Drug Administration Staff Compliance Policy for Combination Product Postmarketing Safety Reporting. FDA Guidance, (April2019).
FDA, CDRH. (2000). Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management. Guidance for Industry and FDA Premarket and Design Control Reviewers, 2–33.
34.
FDA, CDRH. (2011). Applying Human Factors and Usability Engineering to Optimize Medical Device Design. FDA Guidance for Industry, (301), 1–37. https://doi.org/10.1177/1071181311551334
35.
FDA, CDRH. (2016a). Applying Human Factors and Usability Engineering to Medical Devices - Guidance for Industry and Food and Drug Administration Staff. Retrieved from https://www.fda.gov/media/80481/download
FDA, CDRH, CBER. (2018). Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program - Draft Guidance for Industry and Food and Drug Administration Staff. Retrieved October24, 2018, from https://www.fda.gov/media/114034/download
FDA, OCP. (2017). Guidance for Industry and FDA Staff: Current Good Manufacturing Practice for Combination Products. Retrieved October16, 2018, from http://www.fda.gov/oc/combination
HorstD.CaplanS.MauroC.KarnK.SamarasG. (2015). Panel – Challenges in Supporting the Design of Products for Healthcare The Human Factors Consultant’s Perspective. Proceedings of the Human Factors and Ergonomics Society, 2015-Janua, 572–574. https://doi.org/10.1177/1541931215591125
47.
HumphreyW. S. (1999). Pathways to Process Maturity: The Personal Software Process and Team Software Process. SEI Interactive, 2(2), 1-17., (April1998).
48.
IOM. (1999). To Err is Human: Building a Safer Health System. (KohnL. T.CorriganJ. M.DonaldsonM. S., Eds.), National Academy Press. Washington (DC): National Academies Press (US). https://doi.org/10.1017/S095026880100509X
49.
IOM. (2010). Public Health Effectiveness of the FDA 510 ( k )Clearance Process: Balancing Patient Safety and Innovation: Workshop Report. National Academies Press (US) (Vol. 510). Washington (DC).
50.
IOM. (2011). Public Health Effectiveness of the FDA 510(k)Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report. Washington, D.C.: National Academies Press. https://doi.org/10.17226/13020
51.
JokelaT.LalliT. (2003). Usability and CMMI. In CHI ’03 extended abstracts on Human factors in computing systems - CHI ’03 (p. 1010). https://doi.org/10.1145/765891.766121
52.
JugdevK.MollerR. (2006). A retrospective look at our evolving understanding of project success. IEEE Engineering Management Review. https://doi.org/10.1109/EMR.2006.261387
53.
KappesC. M.KershnerJ. R.MorwickT. M.CorriganS. M. (2017). Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen. Journal of Diabetes Science and Technology, 193229681773631. https://doi.org/10.1177/1932296817736316
54.
KayR.StoryM.NguyenQ. (2011). Meet the Human Factors Pre-Market Review Team from FDA (HFES’11 Healthcare Technical Group Invited Address). In Proceedings of the Human Factors and Ergonomics Society Annual Meeting (Vol. 55, pp. 645–645). https://doi.org/10.1177/1071181311551132
55.
LinL.IslaR.DonizK.HarknessH.VicenteK. J.DoyleD. J. (1998). Applying human factors to the design of medical equipment: patient-controlled analgesia. Journal of Clinical Monitoring and Computing, 14(4), 253–263. https://doi.org/10.1023/A:1009928203196
56.
MahonyM. C.PattersonP.HaywardB.NorthR.GreenD. (2015). Human factors engineering and design validation for the redesigned follitropin alfa pen injection device. Expert Opinion on Drug Delivery, 12(5), 715–725.
57.
MDIC. (2015). Quality System Maturity Model for Medical Devices-Medical Device Innovation Consortium (MDIC), (June), 1–37.
MitchellA. E.ColvinH. M.FrenchM. G.ShepherdK. M.GrossblatN.MartinezR. M. (2011). Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process at 35 Years. Public Health (Vol. 510). https://doi.org/10.17226/13150
61.
MitchellJ. (2015). Five Steps to Maturity. The Keil Centre Limited.
PasianB. (2018). Project Management Maturity and Associated Modeling: A Historic, Process-Oriented View. In SilviusG.KarayazG. (Eds.), Developing Organizational Maturity for Effective Project Management (p. 24). IGI Global.
67.
PennypackerJ. S.GrantK. P. (2003). Project Management Maturity: an Industry Benchmark. Project Management Journal, 34(1), 4–11.
68.
PietzschJ. B.AquinoL. M.YockP. G.Paté-CornellM. E.LinehanJ. H. (2007). Review of U.S. Medical Device Regulation. Journal of Medical Devices, 1(4), 283. https://doi.org/10.1115/1.2812429
RappelMJHunterN.AlexandrowA.HairK.ShermanR.CaliffR. (2017). Case Study for Lean Management in the Public Sector: Improving Combination Product Review at the Food and Drug Administration. Clinical and Translational Science, 10(3), 124–127. https://doi.org/10.1111/cts.12441
71.
RojasK. M.CoslerL.ShararehN.SantosD. (2019). Considering the Dynamics of FDA Human Factors Validation Requirement: Implications of Failure and Need to Ensure Project Success – A Conceptual Framework. In Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. Chicago, IL: SAGE Publications.
72.
Santana TapiaR.DanevaM.Van EckP. (2007). Developing an Inter-Enterprise Alignment Maturity Model: Research Challenges and Solutions.
73.
SawyerD. (2000). Medical device requirements, human factors, and the Food and Drug Administration (FDA). In Proceedings of the IEA 2000/HFES 2000 Congress (pp. 526–527). Santa Monica, CA: HFES.
74.
SawyerD.AzizK. J.BackingerC. L.BeersE. T.LoweryA.SykesS. M. (1996). An introduction to human factors in medical devices (do it by design). FDA Guidance.
75.
SchmettowM.SchnittkerR.SchraagenJ. M. (2017). An extended protocol for usability validation of medical devices: Research design and reference model. Journal of Biomedical Informatics, 69, 99–114. https://doi.org/10.1016/J.JBI.2017.03.010
76.
SchmittS. M. (2017). US FDA Device Center Pushes “Total Product Life Cycle” Concept; “Reorganization” Coming, Says Compliance Chief. Medtech Insight: Global Medical Technology News & Analysis.
77.
Sherwood-JonesB.EarthyJ.BowlerY.TaylorR.ForsterM. (1999). A Human Factors Integration Capability Maturity Model. INCOSE International Symposium, 9(1), 1526–1532. https://doi.org/10.1002/j.2334-5837.1999.tb00341.x
VincentC. J.NiezenG.O’KaneA. A.StawarzK. (2015). Can standards and regulations keep up with health technology?JMIR MHealth and UHealth, 3(2), e64. https://doi.org/10.2196/mhealth.3918
WilliamsR.JoffeM.SlonimA. (2016). Health Options Foreclosed: How the FDA Denies Americans the Benefits of Medical Research.
83.
WiyorH.FengX.LinR. (2018). Workshop on Human Factors and Usability Engineering in Medical Device Design & Development. In Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. Boston, MA: HFES.
84.
YorkS. S. (1989). IUD litigation: the Planned Parenthood experience. The American Journal of Gynecologic Health, 3(3-S), 35–37.
85.
ZuckermanD. M.BrownP.NissenS. E. (2011). Medical device recalls and the FDA approval process. Archives of Internal Medicine, 171(11), 1006–1011. https://doi.org/10.1001/archinternmed.2011.30
